| |
How DIP and TD Develop and When to Treat TD and What Are the Ineffective Strategies for Managing TD (Facing the Impact of Tardive Dyskinesia Module 2) |
, , , , , , |
Psychiatry |
Microlearning Series |
| |
VMAT2 Inhibitors – The Recommended Treatment for TD and Which are FDA Approved (Facing the Impact of Tardive Dyskinesia Module 3) |
, , , , , , |
Psychiatry |
Microlearning Series |
| |
TD Is More Than A Movement Disorder, Understanding the TD Prevalence, Risk Factors, and Screening Tools (Facing the Impact of Tardive Dyskinesia Module 1) |
, , , , , , |
Psychiatry |
Microlearning Series |
| |
Deutetrabenazine and Valbenazine: Dose Response, Efficacy, and Safety (Facing the Impact of Tardive Dyskinesia Module 4) |
, , , , , , |
Psychiatry |
Microlearning Series |
| |
Exploring Patient Journeys in the Evolving Therapeutic Landscape of Bladder Cancer (Part 1) |
, , , , , |
Oncology |
On-Demand Webcast |
| |
Exploring Patient Journeys in the Evolving Therapeutic Landscape of Advanced Prostate Cancer (Part 1) |
, , , , , |
Oncology |
On-Demand Webcast |
| |
Exploring Patient Journeys in the Evolving Therapeutic Landscape of Advanced Prostate Cancer (Part 2) |
, , , , , |
Oncology |
On-Demand Webcast |
| |
Exploring Patient Journeys in the Evolving Therapeutic Landscape of Bladder Cancer (Part 2) |
, , , , , |
Oncology |
On-Demand Webcast |
| |
Optimizing Outcomes in Patients with IBS-C: Evidence- Based Strategies to Improve Care |
, , , , |
Gastroenterology, Family medicine |
On-Demand Webcast |
| |
Improving Patient Outcomes in Seborrheic Dermatitis |
, , , , |
Dermatology |
On-Demand Webcast |
